JP Morgan Chase
PMD

JP Morgan Chase’s Psychemedics Corporation PMD Stock Holding History

JP Morgan Chase’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$25 – 7852
2024
Q3 		$25 Sell
11
-1
-8% -$2 ﹤0.01% 7227
2024
Q2 		$29 Hold
12
– – ﹤0.01% 7121
2024
Q1 		$35 Buy
12
+4
+50% +$13 ﹤0.01% 7094
2023
Q4 		$24 Buy
8
+3
+60% +$8 ﹤0.01% 7320
2023
Q3 		$20 Buy
+5
New +$22 ﹤0.01% 7169
2020
Q4 		– Sell
-4
Closed – – 5996
2020
Q3 		$0 Hold
4
– – ﹤0.01% 5850
2020
Q2 		$0 Buy
+4
New +$22 ﹤0.01% 5764
2020
Q1 		– Sell
-980
Closed -$9K – 5805
2019
Q4 		$9K Hold
980
– – ﹤0.01% 5406
2019
Q3 		$9K Sell
980
-5,348
-85% -$45.4K ﹤0.01% 5520
2019
Q2 		$60K Buy
6,328
+5,348
+546% +$60.7K ﹤0.01% 5105
2019
Q1 		$14K Sell
980
-9,976
-91% -$171K ﹤0.01% 5483
2018
Q4 		$174K Buy
10,956
+2,817
+35% +$48.6K ﹤0.01% 4650
2018
Q3 		$153K Buy
8,139
+40
+0.5% +$796 ﹤0.01% 4786
2018
Q2 		$156K Sell
8,099
-10,959
-58% -$222K ﹤0.01% 4675
2018
Q1 		$394K Sell
19,058
-3,700
-16% -$76.8K ﹤0.01% 4118
2017
Q4 		$468K Sell
22,758
-7,761
-25% -$144K ﹤0.01% 4096
2017
Q3 		$558K Buy
30,519
+13,955
+84% +$307K ﹤0.01% 3792
2017
Q2 		$413K Buy
16,564
+1,345
+9% +$28.3K ﹤0.01% 3797
2017
Q1 		$305K Sell
15,219
-7,085
-32% -$156K ﹤0.01% 3906
2016
Q4 		$550K Buy
22,304
+13,772
+161% +$309K ﹤0.01% 3720
2016
Q3 		$169K Buy
+8,532
New +$158K ﹤0.01% 3741

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

JP Morgan Chase's PMD Position: Q4 2024 in Review

JP Morgan Chase sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 11 shares — an estimated $25 sold.

JP Morgan Chase first reported a position in PMD in Q3 2016 and held it in 21 quarters. The position peaked at $558K in Q3 2017. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • JP Morgan Chase reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 11 Psychemedics Corporation shares in Q4 2024, an estimated $25.
  • JP Morgan Chase first reported a position in Psychemedics Corporation in Q3 2016 and held it in 21 quarters.
  • JP Morgan Chase's Psychemedics Corporation position peaked at $558K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.